Gastrobiotic 550 Mg 30 Tablets

Gastrobiotic 550 Mg 30 Tablets

Description:

Gastrobiotic 550 mg 30 tablets is a prescription oral antibiotic medicine containing rifaximin, designed to act locally in the gastrointestinal tract. It is primarily used for the treatment of travelers' diarrhea caused by noninvasive strains of Escherichia coli in patients 12 years of age and older, and as an adjunctive therapy in hepatic encephalopathy to help reduce blood ammonia levels and improve neurological symptoms. Rifaximin is minimally absorbed from the gut, allowing targeted action in the intestines with limited systemic exposure, making it a suitable option for specific gastrointestinal infections and conditions under medical supervision.

Indications:

• Treatment of travelers' diarrhea caused by noninvasive strains of Escherichia coli in patients ≥ 12 years of age.
• Adjunctive treatment of hepatic encephalopathy to reduce blood ammonia concentrations and decrease the severity of neurological manifestations (e.g., confusion, disorientation), as prescribed by a physician.
• Relief of associated gastrointestinal symptoms such as increased stool frequency, loose or watery stools, abdominal discomfort, and urgency related to indicated conditions.
• Use only as directed by a healthcare professional and not for diarrhea due to invasive pathogens (e.g., fever, blood in stool) or non-bacterial causes.

Active Ingredients / Key Components:

• Rifaximin – 550 mg per film-coated tablet.
• Excipients (tablet base, coating agents, stabilizers) – exact composition and concentrations are not specified in the available information (For full ingredient information, please check the product leaflet or the manufacturer’s official website.); please refer to the package insert for full excipient list.

Dosage & Administration / How to Use:

• Use exactly as prescribed by your doctor. Do not exceed the recommended dose or duration.
• Typical adult dosing for travelers' diarrhea and hepatic encephalopathy may vary by indication; follow your physician’s instructions and the official prescribing information. Specific regimen details are not provided in the available data.
• Swallow the tablets whole with a sufficient amount of water. Do not crush, chew, or break the film-coated tablets unless advised by your doctor.
• Can generally be taken with or without food, unless your doctor recommends otherwise.
• If you miss a dose, take it as soon as you remember unless it is almost time for the next dose. Do not double the dose to make up for a missed one.
• Complete the full course of therapy even if symptoms improve early, unless your doctor instructs you to stop.
• For hepatic encephalopathy, long-term or repeated courses may be required under close medical supervision.

Clinical Benefits:

• Targets gut bacteria locally: Rifaximin acts mainly within the intestines with minimal systemic absorption, focusing its effect where it is needed.
• Effective relief of travelers' diarrhea: Helps reduce stool frequency and improve stool consistency in diarrhea caused by noninvasive E. coli strains.
• Supports management of hepatic encephalopathy: Helps lower intestinal production of ammonia and other toxins, contributing to reduced episodes and severity of neurological symptoms.
• Favorable safety profile: Limited systemic absorption may reduce the risk of systemic side effects compared to some other oral antibiotics, when used as directed.

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity to rifaximin, other rifamycin antibiotics (e.g., rifampicin, rifabutin), or any component of the formulation.
• Do not use for diarrhea accompanied by high fever, blood in the stool, or signs of invasive bacterial infection unless specifically directed by a physician.
• Not intended for diarrhea due to viral infections, parasitic infections, or non-infectious causes unless prescribed by a doctor.
• Use with caution in patients with severe liver impairment; dosage adjustment or close monitoring may be required. Always follow your hepatologist’s or physician’s advice.
• Prolonged or repeated use may lead to overgrowth of non-susceptible organisms, including fungi. If superinfection occurs, appropriate therapy should be instituted.
• Consult your doctor before use if pregnant, planning pregnancy, or breastfeeding. The safety of rifaximin in pregnancy and lactation should be individually assessed by a healthcare professional.
• Inform your doctor about all other medications you are taking, including other antibiotics, warfarin or other anticoagulants, and any chronic therapies, to evaluate potential interactions.
• If symptoms worsen, persist beyond the recommended treatment duration, or if new symptoms such as fever, severe abdominal pain, or bloody stools occur, seek medical attention immediately.
• Not intended to diagnose, treat, cure, or prevent any disease outside its approved indications.
• Keep out of reach of children.

Side Effects:

• Common side effects may include nausea, abdominal pain, bloating, flatulence, headache, or increased liver enzymes. These are usually mild and transient.
• Less common side effects can include dizziness, fatigue, constipation, vomiting, or fever.
• Allergic reactions such as rash, itching, swelling (especially of the face, tongue, or throat), severe dizziness, or difficulty breathing require immediate medical attention and discontinuation of the drug.
• Very rarely, antibiotic use may be associated with Clostridioides difficile-associated diarrhea; if you develop persistent or severe diarrhea, inform your doctor promptly.
• If any side effect is severe, persistent, or concerning, contact your healthcare provider for assessment.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Do not use after the expiry date printed on the package. Store at or below the temperature specified on the outer carton, if indicated.

Specifications:

• Form: Film-coated tablets.
• Strength: 550 mg rifaximin per tablet.
• Pack size: 30 film-coated tablets per pack.
• Intended use: Prescription gastrointestinal antibiotic for travelers' diarrhea due to noninvasive E. coli and adjunctive treatment of hepatic encephalopathy, as directed by a physician.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.